Genentech had some great news this week as the Food and Drug Administration has approved Ocrevus, the first drug for an aggressive kind of multiple sclerosis that steadily reduces the ability to walk and coordination. The type of MS, called primary progressive MS, has not had any specific treatments for it as it is pretty … Continue reading “The FDA Just Approved The First Drug For Aggressive Multiple Sclerosis”
